Apple filed a patentinfringement lawsuit against AliveCor, a company that developed the "Kardia Band" for the Apple Watch. Apple and AliveCor are in the middle of a legal battle after Apple was accused of violating antitrust laws.
According to Apple, AliveCor's product line has not been successful with customers, and the company's "failures in the market" have led it to exaggerate its patents against Apple. In order to get an import ban on the Apple Watch, AliveCor filed a complaint with the International Trade Commission.
While it is appealing the ruling, Apple is using the new patent filing to set the record straight as to who is the real pioneer. The filing was from the previous one.
Apple is the pioneering innovator, having researched, developed, and patented core, foundational technologies before AliveCor came into existence. AliveCor's litigation campaign is nothing more than an attempt to siphon from the success of Apple technologies it did not invent, all the while selling products that rely on foundational ECG innovations that Apple patented years before AliveCor came to be.
Apple claims that AliveCor's KardiaMobile, KardiaMobile Card, and Kardia app are in violation of several of its patents.
Apple wants a permanent injunction to stop AliveCor from further violating its patents, as well as damages and legal costs.
The antitrust suit was filed against Apple in May of 2021. According to AliveCor, Apple decided to corner the market for heart rate analysis on Apple watch after seeing the success of its KardiaBand.
Apple is accused of using AliveCor's cardiological detection and analysis technology in its patents.
On Scribd, Apple's full complaint against AliveCor can be found.
All Rights Reserved © 2024
